Pfizer

•

Channel • 7 Shows

Life Sciences

Life Sciences

Updated weekly
Life Sciences

Life Sciences

Monthly
Science Fiction

Science Fiction

Series
Life Sciences

Life Sciences

Updated 21/11/2023
Life Sciences

Life Sciences

Updated 15/12/2025
Medicine

Medicine

Updated 04/12/2024
Medicine

Medicine

Updated weekly

28/10/2025

Part 1 — The Case of the Missing Vaccine

Medical advancements don’t just spring up—they happen by building on decades of previous discoveries. Today, one of these advancements might be on the verge of another breakthrough. But what had to happen first for it to exist? In this episode, co-hosts Dr. Raven Baxter and Dr. Ronald Gamble explore how a vaccine candidate for a deadly, once-mysterious bacterial disease came to be. The story takes them from one doctor’s groundbreaking connection in the 70s, all the way to a real lab where vaccines are being developed today. Featured Guests: – Carol Baker, Pediatric Infectious Disease Specialist – Isis Kanevsky, Senior Director, Vaccines, Pfizer – Ksenia Krylova, Senior Director, Vaccines, Pfizer Dive into the episode here: 02:54 - Getting into the problem 05:11 - The basics of immunity and vaccine science 09:32 - What is a conjugate vaccine? 14:44 - Group B Strep: A case study 22:23 - Talking to a GBS pioneer 31:40 - A trip to the lab 43:08 - What's next, and closing thoughts Season 5 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter and Dr. Ronald Gamble. It’s produced by Acast Creative Studios. Check out our social media platforms to take a deeper look into the labs and stories we discuss during the episodes: Instagram (@pfizerinc), TikTok (@pfizer) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

28/10/2025

•

49 min
04/11/2025

Part 2 — The Mighty, Multifaceted Molecule

The next frontier of medicine is focused on highly targeted drug therapies that could expand the possibilities of individualized patient care. Today, scientists are working on a particular type of molecule that could harness multiple capabilities and treat inflammatory and autoimmune diseases in ways never done before. In this episode, co-hosts Dr. Raven Baxter and Dr. Ronald Gamble explore how the latest advancements in antibody engineering led to multispecific antibodies—powerhouse molecules that can do the jobs of multiple drugs in one. They learn all about what it takes to assemble these antibodies and the impact they could make on patients—with a patient. Featured Guests: – Emma Guttman, Chair of the Department of Dermatology, Icahn School of Medicine at Mount Sinai – Amanda Lopez, Patient, Texas Ambassador for the National Eczema Association – Laird Bloom, Senior Director of Biomedicine Design, Pfizer – Thomas Wynn, Vice President of Discovery, Inflammation & Immunology, Pfizer Dive into the episode here: 1:12 - A metaphor for multispecific antibodies 4:08 - How do multispecific antibodies work? 10:39 - The history behind multispecific antibodies 16:29 - How are multispecific antibody drugs are made? 22:58 - An eczema expert on the potential of multispecific antibodies 29:30 - Amanda Lopez's eczema story 40:14 - What's next, and closing thoughts Season 5 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter and Dr. Ronald Gamble. It’s produced by Acast Creative Studios. Check out our social media platforms to take a deeper look into the labs and stories we discuss during the episodes: Instagram (@pfizerinc), TikTok (@pfizer) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

04/11/2025

•

42 min
19 FEB

The Alarming Rise of Early-Onset Cancers

Why are more young adults getting cancer? That's one of the most pressing questions facing the scientific community today. Traditionally thought of as a disease that affects aging populations, recent data shows that cancer diagnoses for people under the age of 50 are increasing. To tackle this problem, it’ll take a global effort. In this episode you’ll hear from patients, oncologists, researchers and health care providers who are coming together to address this issue head on. Featured guests: – Dr. Marshall Anthony Jr., social scientist and colorectal cancer patient – Dr. Johanna Bendell, Chief Development Officer of Oncology, Pfizer – Dr. Yin Cao, molecular cancer epidemiologist; Cao Lab leader, Washington University – Dr. Beatrice Dionigi, colorectal cancer surgeon; founder & co‑director, Early Onset Colon and Rectal Cancer Project, Columbia Research Cancer Center – Dr. Susan Zhang, Global Development Lead, Pfizer Oncology Dive into the episode here: 00:00 – A patient story reveals an alarming new trend 6:30 – The data behind the rise of early-onset cancer 10:39 – The global search for a cause 14:13 – The unique challenges facing young people with cancer 20:28 – Screening guidelines and what to expect from a colonoscopy 25:17 – The importance of early detection 27:59 – The conclusion of Marshall's cancer journey 30:23 – What's next, and closing thoughts Check out our YouTube channel (@Pfizer) to watch the full interview with Raven & Dr. Marshall Anthony Jr. on his colorectal cancer journey. Season 6 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter. It’s produced by Acast Creative Studios. Hosts in this podcast series were compensated for their time. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

19 Feb

•

34 min
18/11/2025

Part 4 — From Discovery to Delivery: How Scientists Are Revolutionizing Cancer Treatment

In drug discovery and development, every part of the process matters. Scientists learn from every experiment and every observation. In fact, some of the most cutting-edge advancements in medicine are being dreamed up from findings uncovered in the past. In this episode, co-hosts Dr. Raven Baxter and Dr. Ronald Gamble dive deep into antibody drug conjugates, a groundbreaking modality that uses targeted antibody engineering to deliver potent chemotherapy directly to cancer-causing cells. They explore the complex ADC creation process and learn how ADCs are changing the standard of care for bladder cancer, from someone with a personal relationship to the disease. Featured Guests: – Renee Barron-Gores, Caregiver – Phoenix Ho, Vice President, Oncology Early Clinical Development, Pfizer – Sharsti Sandall, Executive Director, ADC Biology, Oncology Research Unit, Pfizer Dive into the episode here: 1:16 - Old ideas yield new discoveries 3:01 - How do antibody drug conjugates work? 5:07 - The origins of ADCs 8:36 - ADCs allow for more targeted cancer treatment 10:44 - How are ADCs structured? 14:16 - How do scientists find the best ADC combinations? 18:27 - Developing oncology drugs 22:02 - ADCs and bladder cancer 24:28 - A caregiver’s perspective on cancer treatment 38:12 - Science Will Win Season 5 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter and Dr. Ronald Gamble. It’s produced by Acast Creative Studios. Check out our social media platforms to take a deeper look into the labs and stories we discuss during the episodes: Instagram (@pfizerinc), TikTok (@pfizer) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

18/11/2025

•

41 min
11/02/2025

Part 1 – The Data Revolution

The intersection of biology and technology is revolutionizing drug discovery. In this episode, host Jeremiah Owyang and expert guests explore the crucial role of data in advancing medical science, from the serendipitous discoveries of the past to the cutting-edge techniques of today. They delve into the history of drug development, the rise of "omics," and the innovative single-cell sequencing that is transforming our understanding of the human body for the benefit of drug discovery. Today, scientists are using vast amounts of data to fuel artificial intelligence models, in the quest for new and better medicines. Featured Guests: – James Lowe, Research Fellow at the University of Exeter – Kellie Kravarik, Associate Research Fellow and Cellular Genomics Group Leader for Systems Immunology at Pfizer – Miguel Garcia-Sancho, Lecturer and Researcher at the University of Edinburgh Season 4 of Science Will Win is created by Pfizer and hosted by Jeremiah Owyang, entrepreneur, investor, and tech industry analyst. It’s produced by Wonder Media Network. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

11/02/2025

•

32 min
26 FEB

Bringing Cancer Into Focus: Biomarkers & Precision Medicine

What if the key to treating cancer was hiding in plain sight – written into its DNA? In this episode of Science Will Win, host Dr. Raven Baxter explores one of the most exciting breakthroughs in cancer care today: the discovery of biomarkers. These tiny molecular signals are helping doctors understand what’s really driving an individual person’s cancer – and opening the door to treatments that can dramatically change patient outcomes. You’ll hear powerful stories from people whose cancers were traced back to a specific biomarker, alongside experts who break down what biomarker testing is, how it works, and why it’s transforming the way we think about cancer treatment. Biomarkers are showing us that when we understand cancer at its molecular level, a disease that once felt like an unsolvable mystery starts to come into focus. Featured guests: – Dr. Ross Camidge, Director of Thoracic Oncology, University of Colorado – Kelly Huffman, Lung Cancer Patient and Retail Account Manager, Pfizer – Karin Tollefson, Chief Oncology Medical Officer, Pfizer Dive into the episode here: 00:00 – An oncologist’s diagnosis introduces the world of biomarker 03:10 – Defining biomarkers and its history 06:24 – Discovery of the first lung cancer biomarker 08:39 – The start Kelly’s lung cancer journey 16:00 – Biomarkers: how do you test for them? 19:11– Discovery of ALK biomarker shift’s Kelly’s story 22:34 – Landscape of targeted therapy and lung cancer today 25:24 – Moving forward with targeted treatments and conclusion Check out our YouTube channel (@Pfizer) to watch the full interview with Raven & Kelly Huffman on her lung cancer journey. Season 6 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter. It’s produced by Acast Creative Studios. Hosts in this podcast series were compensated for their time. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

26 Feb

•

30 min
04/03/2025

Part 4 – New Frontiers in AI & Drug Discovery

So far in this season, we’ve explored how innovations throughout history have brought us to where we are now. We talked about how drug discovery changed from a serendipity-based to data-based endeavor. Then, we explored the powerful hardware and smart software required to accommodate big data. Now, the door to the future of AI in drug discovery is open. In our final episode, we’re looking toward the future, to understand where today’s advancements could potentially take us. Featured Guests: –Charlotte Allerton, Head of Preclinical and Translational Sciences at Pfizer –Daniel Ziemek, Vice President of Integrative Biology and Systems Immunology at Pfizer –Enoch Huang, Head of Machine Learning and Computational Sciences at Pfizer –Dr. Raza Ali, group leader at the University of Cambridge Cancer Research UK Institute, pathologist Season 4 of Science Will Win is created by Pfizer and hosted by Jeremiah Owyang, entrepreneur, investor, and tech industry analyst. It’s produced by Wonder Media Network. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

04/03/2025

•

24 min
22/11/2023

Innovation in cancer: Defining the future of care

Dr Ellie Cannon is joined by Jane Lyons, CEO of Cancer52 and Stefano Podesta, Oncology Lead at Pfizer UK, to discuss the big challenges and opportunities in the fight against cancer within the UK. PP-UNP-GBR-13462 / October 2025 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

22/11/2023

•

43 min
SEASON 1, EPISODE 8

Premonición: Episodio 8 - Resistir

Abel comprueba que estaba muy equivocado en muchas cosas que daba por sentadas sobre Serén. Está descolocado. Piensa en Valdemar. Piensa en Serén y en el grupo de personas tan resistentes que ha conocido. Tiene que volver a Valdemar antes de que lo echen en falta. O quizá para dar la información a sus jefes. Pero a todo esto, el régimen de Valdemar empieza a atacarles y tienen que tomar decisiones ya. En este capítulo intervienen Mariano Venancio, Jorge Machín, Nikki García, Rocío León, Javier Pascual, Carmen Sánchez, Tino Fernández y Maiken Beitia. Premonición es una ficción sonora de Pfizer y El Extraordinario, protagonizada por Nikki García y Jorge Machín. Con las voces de Tino Fernández, Carmen Sánchez, Mariano Venancio, Olga Aguirre, Javier Pascual, Maiken Beitia, Rocío León, Maite Hernández y Dr. Porta. Guion: Álvaro Vera Dirección: Mar Abad Edición de sonido: Andreu Quesada Producción y casting: Marina Alonso-Carriazo y Merche Negro Producción ejecutiva: El Extraordinario y Pfizer Asesoría científica: Dr. Jesús Porta Etessam, presidente de la Sociedad Española de Neurología. Con la colaboración de la Asociación Española de Migraña y Cefalea Portada: Fundi Biela Dirección de arte: Konsu Llorente Making of: Ignacio Izquierdo Música de librería: Konga Music Premonición es una ficción sonora de Pfizer y El Extraordinario. Con la asesoría de la Asociación Española de Migraña y Cefalea. Asesor científico, Dr. Jesús Porta Etessam, presidente de la Sociedad Española de Neurología. Disponible en todas las plataformas. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

S1, E8

•

19 min
SEASON 1, EPISODE 5

Premonición: Episodio 5 - Vivir en potencia

El régimen de Valdemar ha atacado Serén y tienen que pasar la noche en un refugio. A Abel se le está acabando el tiempo y debe regresar a Valdemar. Pero todavía no ha conseguido la información que busca y, en su lugar, descubre que Félix y su padre eran buenos amigos. En Serén todos están impacientes a que Luz mejore de su migraña. Todas las decisiones las consultan con ella porque creen que tiene la capacidad de predecir el futuro. En este capítulo intervienen Nikki García, Carmen Sánchez, Tino Fernández, Jorge Machín, Javier Pascual, Maite Hernández, Maiken Beitia y Olga Aguirre. Premonición es una ficción sonora de Pfizer y El Extraordinario. Con la asesoría de la Asociación Española de Migraña y Cefalea. Asesor científico, Dr. Jesús Porta Etessam, presidente de la Sociedad Española de Neurología. Disponible en todas las plataformas. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

S1, E5

•

18 min

Go behind the breakthroughs and explore the stories of the work we do at Pfizer around the globe, in conversations with the scientists and leaders who make it happen. Listen to recent episodes and follow along.